Landolt C

From WikiMD's WELLNESSPEDIA

Landolt C is an optotype, specifically a type of eye chart used in vision testing, that was developed by the Swiss ophthalmologist Edmond Landolt. The Landolt C is a ring that is broken in one area, and the patient's task is to determine where the ring is broken. The Landolt C is the standard optotype for vision testing in many countries, particularly in Europe.

History[edit]

The Landolt C was developed by Swiss ophthalmologist Edmond Landolt in the late 19th century. Landolt was a pioneer in the field of ophthalmology and made significant contributions to the understanding of eye diseases and vision testing. The Landolt C was one of his most significant contributions, and it remains in use today.

Design[edit]

The design of the Landolt C is simple but effective. It consists of a ring that is broken in one area. The patient's task is to determine where the ring is broken. The size of the C and the gap can be varied to test different levels of visual acuity. The C is usually presented in different orientations, and the patient must identify the direction of the gap.

Use[edit]

The Landolt C is used in a variety of vision tests. It is the standard optotype for vision testing in many countries, particularly in Europe. The Landolt C is also used in research to measure visual acuity and to test the effects of various interventions on vision.

Advantages and Disadvantages[edit]

The Landolt C has several advantages over other types of optotypes. It is simple and quick to administer, and it can be used to test a wide range of visual acuities. However, it also has some disadvantages. Some patients may find it difficult to understand the task, particularly children and those with cognitive impairments. In addition, the Landolt C may not be as effective for testing near vision as other types of optotypes.

See Also[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Landolt_C&oldid=6312797"